• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺功能亢进患者的血浆多形核弹性蛋白酶

Plasma polymorphonuclear elastase in patients with hyperthyroidism.

作者信息

Hara H, Ban Y

机构信息

3rd Department of Internal Medicine, Showa University School of Medicine, Tokyo, Japan.

出版信息

Endocr J. 1993 Dec;40(6):711-4. doi: 10.1507/endocrj.40.711.

DOI:10.1507/endocrj.40.711
PMID:7951541
Abstract

We studied plasma polymorphonuclear elastase (PMNE) levels before and during methimazole treatment in patients with hyperthyroidism. Plasma PMNE levels in patients with hyperthyroidism were significantly higher than those of normal subjects and patients with thyroid adenoma. Plasma PMNE levels in patients with Graves' disease were significantly reduced when their thyroid functions after methimazole treatment were normal, compared with the levels of the patients before treatment. In patients with hyperthyroidism there was a significant positive correlation between plasma PMNE and serum FT3, but no correlation between plasma PMNE and serum TRAb. The results suggested that PMNE was secreted from blood neutrophil in hyperthyroid state patients with Graves' disease and that it was beneficial for helping determining peripheral thyroid function.

摘要

我们研究了甲亢患者在服用甲巯咪唑治疗前及治疗期间的血浆多形核弹性蛋白酶(PMNE)水平。甲亢患者的血浆PMNE水平显著高于正常受试者和甲状腺腺瘤患者。与治疗前相比,格雷夫斯病患者在甲巯咪唑治疗后甲状腺功能正常时,其血浆PMNE水平显著降低。甲亢患者血浆PMNE与血清FT3之间存在显著正相关,但血浆PMNE与血清TRAb之间无相关性。结果表明,PMNE由格雷夫斯病甲亢状态患者的血液中性粒细胞分泌,且有助于判断外周甲状腺功能。

相似文献

1
Plasma polymorphonuclear elastase in patients with hyperthyroidism.甲状腺功能亢进患者的血浆多形核弹性蛋白酶
Endocr J. 1993 Dec;40(6):711-4. doi: 10.1507/endocrj.40.711.
2
Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.采用高浓度聚乙二醇的灵敏促甲状腺素抗体检测法诊断格雷夫斯病。
Clin Exp Pharmacol Physiol. 2004 May-Jun;31(5-6):314-9. doi: 10.1111/j.1440-1681.2004.03991.x.
3
Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.促甲状腺素抗体与格雷夫斯眼病有关,但促甲状腺素结合抑制免疫球蛋白与格雷夫斯病患者的甲状腺功能亢进有关。
Thyroid. 2000 Sep;10(9):809-13. doi: 10.1089/thy.2000.10.809.
4
Erythrocyte carbonic anhydrase-I concentrations in patients with Graves' disease and subacute thyroiditis reflect integrated thyroid hormone levels over the previous few months.格雷夫斯病和亚急性甲状腺炎患者的红细胞碳酸酐酶-I浓度反映了过去几个月的综合甲状腺激素水平。
J Clin Endocrinol Metab. 1991 Feb;72(2):515-8. doi: 10.1210/jcem-72-2-515.
5
Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.促甲状腺激素释放激素对血清甲状腺激素的影响:一项关于未经治疗及已治疗的格雷夫斯病和亚急性甲状腺炎患者的研究。
J Clin Endocrinol Metab. 1995 Jul;80(7):2173-7. doi: 10.1210/jcem.80.7.7608274.
6
Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period.格雷夫斯病患者在甲巯咪唑治疗前、治疗结束时及停药后的血清促甲状腺素受体抗体浓度:促甲状腺素受体抗体活性和/或甲状腺反应在观察期内发生改变的证据
Thyroid. 2006 Mar;16(3):295-302. doi: 10.1089/thy.2006.16.295.
7
Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.尽管促甲状腺激素结合抑制性免疫球蛋白检测结果迅速转阴,但仍存在持续性格雷夫斯甲亢:一例报告
J Med Case Rep. 2017 Feb 6;11(1):32. doi: 10.1186/s13256-017-1214-6.
8
Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.未经治疗的伴有或不伴有促甲状腺素受体抗体(通过猪甲状腺细胞测定)的格雷夫斯病患者的免疫球蛋白,在培养的人甲状腺滤泡中普遍引发强大的甲状腺激素释放活性。
Thyroid. 1999 Oct;9(10):979-88. doi: 10.1089/thy.1999.9.979.
9
Urinary N-acetyl-beta-D-glucosaminidase (NAG) activity in patients with Graves' disease, subacute thyroiditis, and silent thyroiditis: a longitudinal study.格雷夫斯病、亚急性甲状腺炎和寂静性甲状腺炎患者的尿N-乙酰-β-D-氨基葡萄糖苷酶(NAG)活性:一项纵向研究。
Endocrinol Jpn. 1991 Jun;38(3):303-8. doi: 10.1507/endocrj1954.38.303.
10
Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.抗甲状腺药物治疗期间,促甲状腺素抗体和促甲状腺素结合抑制免疫球蛋白水平平稳下降可预测格雷夫斯甲亢的缓解。
Thyroid. 2000 Oct;10(10):891-6. doi: 10.1089/thy.2000.10.891.